|

Prednisolone Clinical Trials

17 actively recruiting trials across 6 locations

Also known as: (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, .delta.1-Hydrocortisone, 15 mg/mL oral solution National Drug Code: 0121-0885-08, Adnisolone, Aprednislon, Capsoid, Cortalone, Corticosteroids, Cortisolone, Dacortin H, Decaprednil, Decortin H, Delta(1)Hydrocortisone, Delta- Cortef, Delta-Cortef, Delta-Diona, Delta-F, Delta-Phoricol, Delta1-dehydro-hydrocortisone, Deltacortril, Deltahydrocortisone, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Metacortandralone, Meti Derm, Meticortelone, Opredsone, Panafcortelone, Pevanti, Precortisyl, Pred, Pred-Clysma, Predeltilone, Predni-Coelin, Predni-Helvacort, Prednicortelone, Prednisolonum, Prednisone, Prelone, Prenilone, Sterane

Other8 trials

Birmingham, Alabama4 trials

Mobile, Alabama1 trial

Gilbert, Arizona1 trial

Tucson, Arizona1 trial

Los Angeles, California1 trial

TReatment for ImmUne Mediated PathopHysiology

Children's Hospital Los Angeles

Phase 2

Tampa, Florida1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.